Ironwood Pharmaceuticals | IRWD - Ordinary Share Capital


Ironwood Pharmaceuticals reported $160K in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 171.09M 1.9M Mar/2026
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Akebia Therapeutics USD 265.42M 199K Dec/2025
Almirall EUR 214.79M 0 Dec/2025
Alnylam Pharmaceuticals USD 133.73M 290K Jun/2026
Amarin USD 20.81M 13K Dec/2025
Ardelyx USD 246.97M 2.62M Mar/2026
Astellas Pharma JPY 1.79B 1.52M Jun/2026
AstraZeneca USD 1.55B 44K Jun/2026
Charles River Laboratories USD 47.73M 439K Jun/2026
Coherus Biosciences USD 121.16M 4.92M Dec/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Halozyme Therapeutics USD 114.04M 4.48M Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
Karyopharm Therapeutics USD 22.54M 4.23M Mar/2026
Lexicon Pharmaceuticals USD 363.47M 67K Dec/2025
MacroGenics USD 63.56M 241K Mar/2026
Moderna USD 391M 2M Sep/2025
Myriad Genetics USD 93.5M 400K Dec/2025
Pacira USD 39.82M 512K Jun/2026
PTC Therapeutics USD 82.88M 1.41M Mar/2026
Puma Biotechnology USD 5K 0 Jun/2024
Sarepta Therapeutics USD 105.62M 53K Jun/2026
Takeda JPY 1.58B 460K Jun/2026
Ultragenyx Pharmaceutical USD 98.3M 1.7M Mar/2026
Vanda Pharmaceuticals USD 58K 0 Dec/2024